Fubing Wu Selected Research

centromere protein F

1/2022	Centromere protein F promotes progression of hepatocellular carcinoma through ERK and cell cycle-associated pathways.
1/2021	Centromere protein F is identified as a novel therapeutic target by genomics profile and contributing to the progression of pancreatic cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Fubing Wu Research Topics

Disease

6	Neoplasms (Cancer) 07/2022 - 01/2020
2	Pancreatic Neoplasms (Pancreatic Cancer) 07/2022 - 01/2021
1	Hepatocellular Carcinoma (Hepatoma) 01/2022
1	Adenocarcinoma of Lung 09/2021
1	Hypoxia (Hypoxemia) 08/2015

Drug/Important Bio-Agent (IBA)

2	Small Interfering RNA (siRNA)IBA 07/2022 - 01/2022
2	EnzymesIBA 07/2022 - 01/2021
2	Biomarkers (Surrogate Marker)IBA 07/2022 - 01/2021
2	Protein Kinase CIBA 07/2022 - 01/2021
2	centromere protein FIBA 01/2022 - 01/2021
2	MicroRNAs (MicroRNA)IBA 01/2020 - 08/2015
1	CateninsIBA 07/2022
1	lysyl- arginyl- alanyl- lysyl- alanyl- lysyl- threonyl- threonyl- lysyl- lysyl- arginine (PKCS)IBA 07/2022
1	ATPases Associated with Diverse Cellular ActivitiesIBA 01/2022
1	Thyroid Hormone Receptors (Thyroid Hormone Receptor)IBA 01/2022
1	Long Noncoding RNAIBA 09/2021
1	IsoenzymesIBA 01/2021
1	Protein Kinase C-thetaIBA 01/2021
1	Proteins (Proteins, Gene)FDA Link 01/2021
1	Pharmaceutical PreparationsIBA 01/2020
1	DNA (Deoxyribonucleic Acid)IBA 01/2020

Therapy/Procedure

2	Therapeutics 01/2021 - 01/2020
1	Immunotherapy 01/2021